https://adisinsight.springer.com/drugsafety/803625861?error=cookies_not_supported&code=3fbaf7a0-1f1f-47ee-87f0-7c2563aa2ba7
Agomelatine - AdisInsight
A 75-year-old man developed drug-induced acute liver during treatment with agomelatine for recurrent depressive disorder.The man, who had type 2 diabetes
agomelatineadisinsight
https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2021.654616/full
Frontiers | Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression,...
1 Insomnia, which is associated with menopausal depression, is a common symptom of menopause. Both symptoms have a common etiology, and can affect each other...
target treatmentfor insomniafrontiersagomelatinepotential
https://www.nice.org.uk/guidance/ta231
Overview | Agomelatine for the treatment of major depressive episodes (terminated appraisal) |...
NICE is unable to recommend the use in the NHS of agomelatine for the treatment of major depressive episodes. This is because Servier did not provide an...
for themajor depressiveoverviewagomelatinetreatment
https://adisinsight.springer.com/drugsafety/803693356?error=cookies_not_supported&code=6519f236-db27-4c44-b655-bc4de3d84909
Agomelatine/mirtazapine/trazodone - AdisInsight
An adult man [exact age not stated] exhibited lack of efficacy during treatment with trazodone, mirtazapine and agomelatine for primer insomnia [routes not
agomelatinemirtazapinetrazodoneadisinsight
https://www.cochrane.org/evidence/CD011271_melatonin-and-agomelatine-prevention-winter-depression
Melatonin and agomelatine for prevention of winter depression | Cochrane
winter depressionmelatoninagomelatinepreventioncochrane
https://www.gov.uk/drug-safety-update/agomelatine-valdoxan-risk-of-liver-toxicity?UNLID=305510885202641815649
Agomelatine (Valdoxan): risk of liver toxicity - GOV.UK
Reminder to test liver function before and during treatment.
agomelatinerisklivertoxicityuk
https://pubmed.ncbi.nlm.nih.gov/32976677/
The safety of agomelatine in standard medical practice in depressed patients: A 26-week...